2018-2019 ISPE Board of Directors Installed at Annual Meeting & Expo

News provided by

International Society for Pharmaceutical Engineering (ISPE)

Nov 15, 2018, 11:00 ET

NORTH BETHESDA, Md. (PRWEB) November 15, 2018 -- The International Society for Pharmaceutical Engineering (ISPE) installed its 2018–2019 International Board of Directors at their 2018 Annual Meeting & Expo, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society.

The following pharmaceutical industry leaders have been elected to the 2018–2019 ISPE International Board of Directors:

Officers:

  • Chair: James Breen Jr., PE, Vice President, Project Lead Biologics Expansion, Janssen Pharmaceuticals
  • Vice Chair: Frances M. Zipp, President and CEO, Lachman Consultant Services, Inc.
  • Treasurer: Thomas Hartman, Vice President of GMP Operations, Biopharm CMC, GlaxoSmithKline
  • Secretary: Joanne R. Barrick, RPh, Advisor, Global Validation Support, Eli Lilly and Company
  • Past Chair: Timothy P. Howard, CPIP, PE, Vice President of Strategy and Development, Commissioning Agents, Inc.

Re-Elected Director:

  • Christine M.V. Moore, PhD, Global Head and Executive Director, GRACS CMC – Policy, Merck

New Directors:

  • Vivianne J. Arencibia, President, Arencibia Quality Compliance Associates, LLC
  • Gunter Baumgartner, Vice President, Global Engineering, Takeda Pharmaceuticals International AG
  • Caroline Rocks, CEng BE MEngSc, Senior Process Engineer, AbbVie, Inc.

Appointed Director:

  • Chris Chen, Chief Executive Officer, WuXi Biologics (Shanghai) Co., Ltd.

Continuing Board Members:
In addition to those named above, the following Directors were elected in 2017 to serve a
two-year term and will continue their service on the Board:

  • Tony (Antonio) Crincoli, PE, Vice President, Global Engineering, Glenmark Pharmaceuticals
  • Flemming Dahl, Senior Vice President, Novo Nordisk A/S
  • Kelly Keen, Vice President Project Management, PMO, Celonic AG
  • Alice Redmond, PhD, Vice President, European Operations, Commissioning Agents, Inc.
  • Michael Rutherford, Executive Director, Computer Systems Quality and Data Integrity, Syneos Health

Young Professionals Representative (Ex Officio):

  • LeAnna Pearson, Manager QA Validation, bluebird bio

Complete biographical information on all of ISPE’s International Board can be found at the ISPE Board of Directors webpage.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information, contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: [email protected]
http://www.ISPE.org

Maria Robertson, International Society for Pharmaceutical Engineering (ISPE), http://www.ISPE.org, 301-364-9207, [email protected]